<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2022-05-16</periodOfReport>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001827506</issuerCik>
        <issuerName>Talaris Therapeutics, Inc.</issuerName>
        <issuerTradingSymbol>TALS</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001639637</rptOwnerCik>
            <rptOwnerName>Smith Karen L.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O TALARIS THERAPEUTICS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>93 WORCESTER STREET</rptOwnerStreet2>
            <rptOwnerCity>WELLESLEY</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>02481</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <footnotes></footnotes>

    <remarks>Exhibit 24:  Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Mary Kay Fenton, as Attorney-in-Fact</signatureName>
        <signatureDate>2022-05-17</signatureDate>
    </ownerSignature>
</ownershipDocument>
